William Blair & Company
PRVL

William Blair & Company’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

William Blair & Company’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,455
Closed -$357K – 1935
2020
Q4 		$357K Buy
+15,455
New +$357K ﹤0.01% 1191